Technical Description
The technology introduces a novel process for synthesizing carbon nanocapsules from neem seeds, designed for targeted treatment of invasive ductal carcinoma and triple-negative breast cancer.
Problems Addressed
- Cancer Treatment Toxicity
- Quantum Dot Biocompatibility
- Drug Delivery Inefficiency
- High Therapy Costs
- Mass Production Limitations
- Limited Tumor Marker Detection
Tech Features
- Efficient Carbon Synthesis
- Enhanced Biocompatibility
- Eco-Friendly Production
- Optimized Nanocapsule Size
- Superior Fluorescence Stability
- High Cytoplasmic Absorption
Target Audience
- Pharmaceutical Industry
- Biotechnology Research Centers
- Nanomedicine Development Firms
- Healthcare & Hospitals
- Academic & Research Institutions
Tech ID: P26-1363 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
